{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:15:03Z","timestamp":1793315703669,"version":"4.5.0"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["67334"],"award-info":[{"award-number":["67334"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02744-4","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T12:52:22Z","timestamp":1748177542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The role and diagnostic value of deregulated miRNAs in cervical cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Masoumeh","family":"Parvizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Jeddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Bakhshandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Eghdam-Zamiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noushin","family":"Mobaraki-Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Esmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-8502","authenticated-orcid":false,"given":"Abbas","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"issue":"8","key":"2744_CR1","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","volume":"10","author":"L Bruni","year":"2022","unstructured":"Bruni L, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 2022;10(8):e1115\u201327.","journal-title":"Lancet Glob Health"},{"issue":"12","key":"2744_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2023.110724","volume":"84","author":"S Patra","year":"2023","unstructured":"Patra S, et al. Function of gamma delta (\u03b3\u03b4) T cell in cancer with special emphasis on cervical cancer. Hum Immunol. 2023;84(12): 110724.","journal-title":"Hum Immunol"},{"issue":"1","key":"2744_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, et al. Cancer statistics, 2023. Ca Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"Ca Cancer J Clin"},{"issue":"2","key":"2744_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0001598","volume":"3","author":"SK Smith","year":"2023","unstructured":"Smith SK, et al. Performance of screening tools for cervical neoplasia among women in low-and middle-income countries: a systematic review and meta-analysis. PLOS Global Public Health. 2023;3(2): e0001598.","journal-title":"PLOS Global Public Health"},{"key":"2744_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-2-35","volume":"2","author":"L Peirson","year":"2013","unstructured":"Peirson L, et al. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013;2:1\u201314.","journal-title":"Syst Rev"},{"issue":"9","key":"2744_CR6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1136\/ijgc-2022-003728","volume":"32","author":"AA Francoeur","year":"2022","unstructured":"Francoeur AA, et al. The increasing incidence of stage IV cervical cancer in the USA: what factors are related? Int J Gynecol Cancer. 2022;32(9):1115\u201322.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2744_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41597-023-02359-w","volume":"10","author":"S Lu","year":"2023","unstructured":"Lu S, et al. A multi-omics dataset of human transcriptome and proteome stable reference. Scientific Data. 2023;10(1):455.","journal-title":"Scientific Data"},{"issue":"1","key":"2744_CR8","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1038\/s41467-022-32791-2","volume":"13","author":"W Hu","year":"2022","unstructured":"Hu W, et al. Single-cell transcriptome and translatome dual-omics reveals potential mechanisms of human oocyte maturation. Nat Commun. 2022;13(1):5114.","journal-title":"Nat Commun"},{"key":"2744_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41576-023-00611-y","volume":"24","author":"R Shang","year":"2023","unstructured":"Shang R, et al. microRNAs in action: biogenesis, function and regulation. Nat Rev Gene. 2023;24:1\u201318.","journal-title":"Nat Rev Gene"},{"issue":"9","key":"2744_CR10","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/molbev\/msw089","volume":"33","author":"Y Wang","year":"2016","unstructured":"Wang Y, et al. microRNAs in the same clusters evolve to coordinately regulate functionally related genes. Mol Biol Evol. 2016;33(9):2232\u201347.","journal-title":"Mol Biol Evol"},{"issue":"6","key":"2744_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrc3932","volume":"15","author":"S Lin","year":"2015","unstructured":"Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15(6):321\u201333.","journal-title":"Nat Rev Cancer"},{"key":"2744_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fsigen.2014.09.002","volume":"14","author":"SS Silva","year":"2015","unstructured":"Silva SS, et al. Forensic miRNA: potential biomarker for body fluids? Forensic Sci Int Genet. 2015;14:1\u201310.","journal-title":"Forensic Sci Int Genet"},{"issue":"1","key":"2744_CR13","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1038\/s41598-020-62534-6","volume":"10","author":"C Cui","year":"2020","unstructured":"Cui C, Cui Q. The relationship of human tissue microRNAs with those from body fluids. Sci Rep. 2020;10(1):5644.","journal-title":"Sci Rep"},{"issue":"1112","key":"2744_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbagrm.2011.05.005","volume":"1809","author":"Z-M Zheng","year":"2011","unstructured":"Zheng Z-M, Wang X. Regulation of cellular miRNA expression by human papillomaviruses. Biochimica et Biophysica Acta Gene Regulat Mechan. 2011;1809(1112):668\u201377.","journal-title":"Biochimica et Biophysica Acta Gene Regulat Mechan"},{"key":"2744_CR15","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s11033-013-2998-0","volume":"41","author":"J Ribeiro","year":"2014","unstructured":"Ribeiro J, Sousa H. MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a. Mol Biol Rep. 2014;41:1525\u201331.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"2744_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","volume":"52","author":"M Zapatka","year":"2020","unstructured":"Zapatka M, et al. The landscape of viral associations in human cancers. Nat Genet. 2020;52(3):320\u201330.","journal-title":"Nat Genet"},{"issue":"11","key":"2744_CR17","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41579-018-0064-6","volume":"16","author":"NA Krump","year":"2018","unstructured":"Krump NA, You J. Molecular mechanisms of viral oncogenesis in humans. Nat Rev Microbiol. 2018;16(11):684\u201398.","journal-title":"Nat Rev Microbiol"},{"key":"2744_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-9378-2-21","volume":"2","author":"N Reddout","year":"2007","unstructured":"Reddout N, et al. High risk HPV types 18 and 16 are potent modulators of oral squamous cell carcinoma phenotypes in vitro. Infect Agents Cancer. 2007;2:1\u201311.","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"2744_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/jmv.24902","volume":"90","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, et al. Assessment of the effectiveness of HPV16\/18 infection referred for colposcopy in cervical cancer screening in Northwest of China. J Med Virol. 2018;90(1):165\u201371.","journal-title":"J Med Virol"},{"issue":"1","key":"2744_CR20","doi-asserted-by":"publisher","first-page":"14064","DOI":"10.1038\/s41598-021-93485-1","volume":"11","author":"RP Mendoza","year":"2021","unstructured":"Mendoza RP, et al. Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer. Sci Rep. 2021;11(1):14064.","journal-title":"Sci Rep"},{"issue":"17","key":"2744_CR21","doi-asserted-by":"publisher","first-page":"17592","DOI":"10.1002\/cam4.6377","volume":"12","author":"A Karimi","year":"2023","unstructured":"Karimi A, et al. Predictive impact of human papillomavirus circulating tumor DNA in treatment response monitoring of HPV-associated cancers; a meta-analysis on recurrent event endpoints. Cancer Med. 2023;12(17):17592\u2013602.","journal-title":"Cancer Med"},{"issue":"1","key":"2744_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41598-017-00364-9","volume":"7","author":"Y Liu","year":"2017","unstructured":"Liu Y, et al. Whole-genome analysis of human papillomavirus types 16, 18, and 58 isolated from cervical Precancer and Cancer samples in Chinese women. Sci Rep. 2017;7(1):263.","journal-title":"Sci Rep"},{"issue":"9780470015902","key":"2744_CR23","volume":"10","author":"W Lucas","year":"2010","unstructured":"Lucas W, Knipe DM. Viral capsids and envelopes: structure and function. Encyclopedia Life Sci. 2010;10(9780470015902): a0001091.","journal-title":"Encyclopedia Life Sci"},{"key":"2744_CR24","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.3389\/fmicb.2018.02896","volume":"9","author":"X Wang","year":"2018","unstructured":"Wang X, Huang X, Zhang Y. Involvement of human papillomaviruses in cervical cancer. Front Microbiol. 2018;9:2896.","journal-title":"Front Microbiol"},{"issue":"1","key":"2744_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2217\/fvl.10.73","volume":"6","author":"VM Williams","year":"2011","unstructured":"Williams VM, et al. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Futur Virol. 2011;6(1):45\u201357.","journal-title":"Futur Virol"},{"issue":"2","key":"2744_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1101\/gr.164806.113","volume":"24","author":"K Akagi","year":"2014","unstructured":"Akagi K, et al. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res. 2014;24(2):185\u201399.","journal-title":"Genome Res"},{"issue":"19","key":"2744_CR27","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.3390\/cancers14194623","volume":"14","author":"VL Porter","year":"2022","unstructured":"Porter VL, Marra MA. The drivers, mechanisms, and consequences of genome instability in HPV-driven cancers. Cancers. 2022;14(19):4623.","journal-title":"Cancers"},{"issue":"5","key":"2744_CR28","doi-asserted-by":"publisher","first-page":"048","DOI":"10.1093\/femspd\/ftz048","volume":"77","author":"N Hemmat","year":"2019","unstructured":"Hemmat N, Bannazadeh Baghi H. Association of human papillomavirus infection and inflammation in cervical cancer. Pathog Dis. 2019;77(5):048.","journal-title":"Pathog Dis"},{"issue":"3","key":"2744_CR29","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3892\/ol.2015.2884","volume":"9","author":"JV Fernandes","year":"2015","unstructured":"Fernandes JV, et al. Link between chronic inflammation and human papillomavirus-induced carcinogenesis. Oncol Lett. 2015;9(3):1015\u201326.","journal-title":"Oncol Lett"},{"key":"2744_CR30","doi-asserted-by":"publisher","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","volume":"30","author":"A-B Moscicki","year":"2012","unstructured":"Moscicki A-B, et al. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine. 2012;30:F24\u201333.","journal-title":"Vaccine"},{"issue":"6","key":"2744_CR31","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1067\/moe.2001.115392","volume":"91","author":"CS Miller","year":"2001","unstructured":"Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982\u20131997. Oral Surgery Oral Med Oral Pathol Oral Radiol Endodontol. 2001;91(6):622\u201335.","journal-title":"Oral Surgery Oral Med Oral Pathol Oral Radiol Endodontol"},{"issue":"4","key":"2744_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00117-22","volume":"10","author":"A Karimi","year":"2022","unstructured":"Karimi A, et al. Human papillomavirus and risk of head and neck squamous cell carcinoma in Iran. Microbiol Spectr. 2022;10(4): e0011722.","journal-title":"Microbiol Spectr"},{"issue":"2","key":"2744_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0738-081X(97)00009-6","volume":"15","author":"F Breitburd","year":"1997","unstructured":"Breitburd F, Salmon J, Orth G. The rabbit viral skin papillomas and carcinomas: a model for the immunogenetics of HPV-associated carcinogenesis. Clin Dermatol. 1997;15(2):237\u201347.","journal-title":"Clin Dermatol"},{"issue":"12","key":"2744_CR34","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1099\/vir.0.2008\/004457-0","volume":"89","author":"S Roperto","year":"2008","unstructured":"Roperto S, et al. Detection of bovine papillomavirus type 2 in the peripheral blood of cattle with urinary bladder tumours: possible biological role. J Gen Virol. 2008;89(12):3027\u201333.","journal-title":"J Gen Virol"},{"key":"2744_CR35","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.biopha.2018.06.149","volume":"106","author":"RP Araldi","year":"2018","unstructured":"Araldi RP, et al. The human papillomavirus (HPV)-related cancer biology: an overview. Biomed Pharmacother. 2018;106:1537\u201356.","journal-title":"Biomed Pharmacother"},{"key":"2744_CR36","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.3389\/fmicb.2017.02253","volume":"8","author":"HW Haverkos","year":"2017","unstructured":"Haverkos HW, Haverkos GP, O\u2019Mara M. Co-carcinogenesis: human papillomaviruses, coal tar derivatives, and squamous cell cervical cancer. Front Microbiol. 2017;8:2253.","journal-title":"Front Microbiol"},{"issue":"1","key":"2744_CR37","doi-asserted-by":"publisher","first-page":"12556","DOI":"10.1038\/s41598-019-49060-w","volume":"9","author":"E Park","year":"2019","unstructured":"Park E, et al. Carcinogenic risk of human papillomavirus (HPV) genotypes and potential effects of HPV vaccines in Korea. Sci Rep. 2019;9(1):12556.","journal-title":"Sci Rep"},{"key":"2744_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.virusres.2016.12.017","volume":"231","author":"N Egawa","year":"2017","unstructured":"Egawa N, Doorbar J. The low-risk papillomaviruses. Virus Res. 2017;231:119\u201327.","journal-title":"Virus Res"},{"issue":"5","key":"2744_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner M, et al. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022;19(5):306\u201327.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"2744_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164701","volume":"11","author":"D Gao","year":"2016","unstructured":"Gao D, et al. miRNA expression profiles of HPV-infected patients with cervical cancer in the Uyghur population in China. PLoS ONE. 2016;11(10): e0164701.","journal-title":"PLoS ONE"},{"key":"2744_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.758337","volume":"8","author":"EG Ba\u00f1uelos-Villegas","year":"2021","unstructured":"Ba\u00f1uelos-Villegas EG, P\u00e9rez-yP\u00e9rez MF, Alvarez-Salas LM. Cervical cancer, papillomavirus, and miRNA dysfunction. Front Mol Biosci. 2021;8: 758337.","journal-title":"Front Mol Biosci"},{"issue":"11","key":"2744_CR42","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41419-018-1059-y","volume":"9","author":"S Yao","year":"2018","unstructured":"Yao S, et al. Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways. Cell Death Dis. 2018;9(11):1055.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2744_CR43","doi-asserted-by":"publisher","first-page":"9033","DOI":"10.1038\/s41598-020-65850-z","volume":"10","author":"S Du","year":"2020","unstructured":"Du S, et al. Applying serum proteins and microRNA as novel biomarkers for early-stage cervical cancer detection. Sci Rep. 2020;10(1):9033.","journal-title":"Sci Rep"},{"key":"2744_CR44","first-page":"1","volume":"24","author":"P Mandal","year":"2025","unstructured":"Mandal P, Sengupta B, Paul S. Role of miR-23b in the carcinogenesis and therapeutics of cervical cancer. The Nucleus. 2025;24:1\u201316.","journal-title":"The Nucleus"},{"issue":"8","key":"2744_CR45","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3727\/096504017X15021536183526","volume":"26","author":"J Feng","year":"2018","unstructured":"Feng J. Upregulation of microRNA-4262 targets Kaiso (ZBTB33) to inhibit the proliferation and EMT of cervical cancer cells. Oncol Res. 2018;26(8):1215.","journal-title":"Oncol Res"},{"issue":"1","key":"2744_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07478-w","volume":"20","author":"J Liu","year":"2020","unstructured":"Liu J, et al. Upregulation of miR-205 induces CHN1 expression, which is associated with the aggressive behaviour of cervical cancer cells and correlated with lymph node metastasis. BMC Cancer. 2020;20(1):1\u201313.","journal-title":"BMC Cancer"},{"key":"2744_CR47","doi-asserted-by":"crossref","unstructured":"Xie H et al. miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. 2012.","DOI":"10.1371\/journal.pone.0046990"},{"issue":"6","key":"2744_CR48","doi-asserted-by":"publisher","first-page":"101042831770130","DOI":"10.1177\/1010428317701308","volume":"39","author":"H Pang","year":"2017","unstructured":"Pang H, Yue X. MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer. Tumor Biology. 2017;39(6):1010428317701308.","journal-title":"Tumor Biology"},{"issue":"8","key":"2744_CR49","doi-asserted-by":"publisher","first-page":"e760","DOI":"10.1038\/cddis.2013.272","volume":"4","author":"Y-D Wang","year":"2013","unstructured":"Wang Y-D, et al. OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b\/BAK1 pathway. Cell Death Dis. 2013;4(8):e760\u2013e760.","journal-title":"Cell Death Dis"},{"key":"2744_CR50","doi-asserted-by":"crossref","unstructured":"Gu X et al. MiR-499a-5p inhibits proliferation, invasion, migration, and epithelial\u2013mesenchymal transition, and enhances radiosensitivity of cervical cancer cells via targeting EIF4E. OncoTargets Therapy. 2020: p. 2913\u20132924.","DOI":"10.2147\/OTT.S241631"},{"issue":"1","key":"2744_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-05162-x","volume":"7","author":"A Tyagi","year":"2017","unstructured":"Tyagi A, et al. Cervical cancer stem cells manifest radioresistance: association with upregulated AP-1 activity. Sci Rep. 2017;7(1):1\u201314.","journal-title":"Sci Rep"},{"issue":"1","key":"2744_CR52","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1038\/s41467-023-38318-7","volume":"14","author":"SJ Oh","year":"2023","unstructured":"Oh SJ, et al. TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway. Nat Commun. 2023;14(1):2691.","journal-title":"Nat Commun"},{"issue":"1","key":"2744_CR53","doi-asserted-by":"publisher","first-page":"18946","DOI":"10.1038\/s41598-023-46340-4","volume":"13","author":"B Wolf","year":"2023","unstructured":"Wolf B, et al. Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype. Sci Rep. 2023;13(1):18946.","journal-title":"Sci Rep"},{"issue":"1","key":"2744_CR54","doi-asserted-by":"publisher","first-page":"17727","DOI":"10.1038\/s41598-019-54177-z","volume":"9","author":"L Jing","year":"2019","unstructured":"Jing L, et al. Sema4C mediates EMT inducing chemotherapeutic resistance of miR-31-3p in cervical cancer cells. Sci Rep. 2019;9(1):17727.","journal-title":"Sci Rep"},{"issue":"2","key":"2744_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41419-022-05547-5","volume":"14","author":"C Chi","year":"2023","unstructured":"Chi C, et al. PDHB-AS suppresses cervical cancer progression and cisplatin resistance via inhibition on Wnt\/\u03b2-catenin pathway. Cell Death Dis. 2023;14(2):90.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2744_CR56","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/CAD.0000000000000871","volume":"31","author":"Q Liu","year":"2020","unstructured":"Liu Q, Liu S, Wang D. Overexpression of microRNA-21 decreased the sensitivity of advanced cervical cancer to chemoradiotherapy through SMAD7. Anticancer Drugs. 2020;31(3):272\u201381.","journal-title":"Anticancer Drugs"},{"issue":"5","key":"2744_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/kjm2.12348","volume":"37","author":"DS Yu","year":"2021","unstructured":"Yu DS, Song XL, Yan C. Oncogenic miRNA-1908 targets HDAC10 and promotes the aggressive phenotype of cervical cancer cell. Kaohsiung J Med Sci. 2021;37(5):402\u201310.","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"2744_CR58","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbrc.2015.01.066","volume":"458","author":"C Zhou","year":"2015","unstructured":"Zhou C, et al. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7. Biochem Biophys Res Commun. 2015;458(1):63\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2744_CR59","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bbrc.2015.02.138","volume":"459","author":"L-Q Wang","year":"2015","unstructured":"Wang L-Q, et al. MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer. Biochem Biophys Res Commun. 2015;459(3):515\u201320.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2744_CR60","first-page":"2990","volume":"22","author":"M Wang","year":"2020","unstructured":"Wang M, Wang X, Liu W. MicroRNA-130a-3p promotes the proliferation and inhibits the apoptosis of cervical cancer cells via negative regulation of RUNX3. Mol Med Rep. 2020;22(4):2990\u20133000.","journal-title":"Mol Med Rep"},{"issue":"9","key":"2744_CR61","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41419-019-1841-5","volume":"10","author":"Q Sun","year":"2019","unstructured":"Sun Q, et al. A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3\/AKT\/NF-\u03baB and TIMP3\/MMP9 pathways in cervical cancer cells. Cell Death Dis. 2019;10(9):636.","journal-title":"Cell Death Dis"},{"key":"2744_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12867-015-0052-6","volume":"16","author":"J Li","year":"2015","unstructured":"Li J, et al. microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4. BMC Mol Biol. 2015;16:1\u20139.","journal-title":"BMC Mol Biol"},{"issue":"4","key":"2744_CR63","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/15548627.2018.1539590","volume":"15","author":"Z Yang","year":"2019","unstructured":"Yang Z, et al. GRSF1-mediated MIR-G-1 promotes malignant behavior and nuclear autophagy by directly upregulating TMED5 and LMNB1 in cervical cancer cells. Autophagy. 2019;15(4):668\u201385.","journal-title":"Autophagy"},{"issue":"1","key":"2744_CR64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ygyno.2014.04.047","volume":"134","author":"N Wang","year":"2014","unstructured":"Wang N, et al. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. Gynecol Oncol. 2014;134(1):129\u201337.","journal-title":"Gynecol Oncol"},{"issue":"35","key":"2744_CR65","doi-asserted-by":"publisher","first-page":"57254","DOI":"10.18632\/oncotarget.11138","volume":"7","author":"W-C Lu","year":"2016","unstructured":"Lu W-C, et al. miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma. Oncotarget. 2016;7(35):57254.","journal-title":"Oncotarget"},{"key":"2744_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cbi.2018.02.024","volume":"285","author":"JGP Sanches","year":"2018","unstructured":"Sanches JGP, et al. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD. Chem Biol Interact. 2018;285:85\u201395.","journal-title":"Chem Biol Interact"},{"issue":"2","key":"2744_CR67","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.canlet.2012.05.022","volume":"324","author":"M-J Long","year":"2012","unstructured":"Long M-J, et al. MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. Cancer Lett. 2012;324(2):186\u201396.","journal-title":"Cancer Lett"},{"key":"2744_CR68","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10456-019-09665-1","volume":"22","author":"X-G Wu","year":"2019","unstructured":"Wu X-G, et al. Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma. Angiogenesis. 2019;22:397\u2013410.","journal-title":"Angiogenesis"},{"issue":"3","key":"2744_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120905","volume":"10","author":"S Zhao","year":"2015","unstructured":"Zhao S, et al. MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo. PLoS ONE. 2015;10(3): e0120905.","journal-title":"PLoS ONE"},{"issue":"6","key":"2744_CR70","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.febslet.2012.02.020","volume":"586","author":"H-W Kang","year":"2012","unstructured":"Kang H-W, et al. miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. FEBS Lett. 2012;586(6):897\u2013904.","journal-title":"FEBS Lett"},{"key":"2744_CR71","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejphar.2018.11.043","volume":"844","author":"Q Zhou","year":"2019","unstructured":"Zhou Q, et al. MicroRNA-20a regulates cell proliferation, apoptosis and autophagy by targeting thrombospondin 2 in cervical cancer. Eur J Pharmacol. 2019;844:102\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"2744_CR72","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/bjc.2013.829","volume":"110","author":"T Hou","year":"2014","unstructured":"Hou T, et al. MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1. Br J Cancer. 2014;110(5):1260\u20138.","journal-title":"Br J Cancer"},{"issue":"4","key":"2744_CR73","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.bbrc.2013.09.142","volume":"440","author":"J Zhang","year":"2013","unstructured":"Zhang J, et al. miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells. Biochem Biophys Res Commun. 2013;440(4):582\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2744_CR74","doi-asserted-by":"publisher","first-page":"180","DOI":"10.14715\/cmb\/2020.66.7.27","volume":"66","author":"Y Qiu","year":"2020","unstructured":"Qiu Y, et al. miR-196a targeting LRIG3 promotes the proliferation and migration of cervical cancer cells. Cell Mol Biol. 2020;66(7):180\u20135.","journal-title":"Cell Mol Biol"},{"issue":"1","key":"2744_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s43032-021-00788-9","volume":"29","author":"H Sun","year":"2022","unstructured":"Sun H, Chen X. MiR-106b-5p promotes malignant behaviors of cervical squamous cell carcinoma cells by targeting TIMP2. Reprod Sci. 2022;29(1):203\u201311.","journal-title":"Reprod Sci"},{"issue":"6","key":"2744_CR76","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.3892\/or.2015.3931","volume":"33","author":"J Xu","year":"2015","unstructured":"Xu J, et al. Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN. Oncol Rep. 2015;33(6):3108\u201316.","journal-title":"Oncol Rep"},{"issue":"9","key":"2744_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162378","volume":"11","author":"Y Huang","year":"2016","unstructured":"Huang Y, et al. Over-expressed miR-224 promotes the progression of cervical cancer via targeting RASSF8. PLoS ONE. 2016;11(9): e0162378.","journal-title":"PLoS ONE"},{"issue":"12","key":"2744_CR78","doi-asserted-by":"publisher","first-page":"10278","DOI":"10.1002\/jcb.27370","volume":"119","author":"LM Yu","year":"2018","unstructured":"Yu LM, et al. MicroRNA-224 inhibition prevents progression of cervical carcinoma by targeting PTX3. J Cell Biochem. 2018;119(12):10278\u201390.","journal-title":"J Cell Biochem"},{"key":"2744_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0770-2","volume":"7","author":"S Chen","year":"2019","unstructured":"Chen S, et al. Mechanisms regulating PD-L1 expression on tumor and immune cells. J Immunother Cancer. 2019;7:1\u201312.","journal-title":"J Immunother Cancer"},{"issue":"12","key":"2744_CR80","doi-asserted-by":"publisher","first-page":"11933","DOI":"10.1007\/s13277-014-2479-7","volume":"35","author":"G Lao","year":"2014","unstructured":"Lao G, et al. Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1. Tumor Biology. 2014;35(12):11933\u20138.","journal-title":"Tumor Biology"},{"key":"2744_CR81","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.2147\/OTT.S197740","volume":"12","author":"B Sun","year":"2019","unstructured":"Sun B, et al. The proliferation of cervical cancer is promoted by miRNA-125b through the regulation of the HMGA1. Onco Targets Ther. 2019;12:2767.","journal-title":"Onco Targets Ther"},{"issue":"8","key":"2744_CR82","first-page":"3591","volume":"13","author":"F Gao","year":"2023","unstructured":"Gao F, et al. miR-182 promotes cervical cancer progression via activating the Wnt\/\u03b2-catenin axis. Am J Cancer Res. 2023;13(8):3591.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"2744_CR83","first-page":"4755","volume":"8","author":"J Sun","year":"2015","unstructured":"Sun J, et al. miR-182 induces cervical cancer cell apoptosis through inhibiting the expression of DNMT3a. Int J Clin Exp Pathol. 2015;8(5):4755.","journal-title":"Int J Clin Exp Pathol"},{"key":"2744_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-013-0751-0","volume":"30","author":"X Wu","year":"2013","unstructured":"Wu X, et al. MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition. Med Oncol. 2013;30:1\u201312.","journal-title":"Med Oncol"},{"key":"2744_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.768918","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Mechanisms of action and clinical implications of MicroRNAs in the drug resistance of gastric cancer. Front Oncol. 2021;11: 768918.","journal-title":"Front Oncol"},{"key":"2744_CR86","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4784500","volume":"2023","author":"W Wang","year":"2023","unstructured":"Wang W, et al. miR-19-3p targets PTEN to regulate cervical cancer cell proliferation, invasion, and autophagy. Genetics Research. 2023;2023: e20.","journal-title":"Genetics Research"},{"key":"2744_CR87","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10495-019-01588-y","volume":"25","author":"Y Chen","year":"2020","unstructured":"Chen Y, et al. microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6. Apoptosis. 2020;25:205\u201316.","journal-title":"Apoptosis"},{"issue":"6","key":"2744_CR88","first-page":"3015","volume":"39","author":"Q Hu","year":"2018","unstructured":"Hu Q, et al. miR-146a promotes cervical cancer cell viability via targeting IRAK1 and TRAF6. Oncol Rep. 2018;39(6):3015\u201324.","journal-title":"Oncol Rep"},{"key":"2744_CR89","doi-asserted-by":"publisher","first-page":"153303382093413","DOI":"10.1177\/1533033820934132","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Chen R, Shao J. MicroRNA-96-5p facilitates the viability, migration, and invasion and suppresses the apoptosis of cervical cancer cells bynegatively modulating SFRP4. Technol Cancer Res Treat. 2020;19:1533033820934132.","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"2744_CR90","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s13577-021-00649-2","volume":"35","author":"L Ren","year":"2022","unstructured":"Ren L, et al. The promotional effect of microRNA-103a-3p in cervical cancer cells by regulating the ubiquitin ligase FBXW7 function. Hum Cell. 2022;35(2):472\u201385.","journal-title":"Hum Cell"},{"issue":"2","key":"2744_CR91","doi-asserted-by":"publisher","first-page":"142","DOI":"10.7150\/ijms.21645","volume":"15","author":"K-T Lv","year":"2018","unstructured":"Lv K-T, et al. MiR-22-3p regulates cell proliferation and inhibits cell apoptosis through targeting the eIF4EBP3 gene in human cervical squamous carcinoma cells. Int J Med Sci. 2018;15(2):142.","journal-title":"Int J Med Sci"},{"key":"2744_CR92","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.biopha.2018.03.019","volume":"102","author":"H Zhang","year":"2018","unstructured":"Zhang H, et al. The mechanisms involved in miR-9 regulated apoptosis in cervical cancer by targeting FOXO3. Biomed Pharmacother. 2018;102:626\u201332.","journal-title":"Biomed Pharmacother"},{"key":"2744_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-13-118","volume":"13","author":"B Zhang","year":"2013","unstructured":"Zhang B, et al. A specific miRNA signature promotes radioresistance of human cervical cancer cells. Cancer Cell Int. 2013;13:1\u20138.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2744_CR94","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/s41598-020-60143-x","volume":"10","author":"GE Campos-Viguri","year":"2020","unstructured":"Campos-Viguri GE, et al. MiR-23b-3p reduces the proliferation, migration and invasion of cervical cancer cell lines via the reduction of c-Met expression. Sci Rep. 2020;10(1):3256.","journal-title":"Sci Rep"},{"issue":"3","key":"2744_CR95","first-page":"753","volume":"5","author":"L Liu","year":"2012","unstructured":"Liu L, et al. miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Mol Med Rep. 2012;5(3):753\u201360.","journal-title":"Mol Med Rep"},{"issue":"6","key":"2744_CR96","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3727\/096504017X15037506066252","volume":"26","author":"X Wang","year":"2018","unstructured":"Wang X, Xie Y, Wang J. Overexpression of microRNA-34a-5p inhibits proliferation and promotes apoptosis of human cervical cancer cells by downregulation of Bcl-2. Oncol Res. 2018;26(6):977.","journal-title":"Oncol Res"},{"issue":"2","key":"2744_CR97","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1038\/oncsis.2016.1","volume":"5","author":"Z Fan","year":"2016","unstructured":"Fan Z, et al. MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression. Oncogenesis. 2016;5(2):e197\u2013e197.","journal-title":"Oncogenesis"},{"issue":"1","key":"2744_CR98","doi-asserted-by":"publisher","first-page":"10323","DOI":"10.1038\/s41598-021-89388-w","volume":"11","author":"M Aftab","year":"2021","unstructured":"Aftab M, et al. Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer. Sci Rep. 2021;11(1):10323.","journal-title":"Sci Rep"},{"issue":"5","key":"2744_CR99","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.3892\/ol.2017.5852","volume":"13","author":"P Zhang","year":"2017","unstructured":"Zhang P, et al. MicroRNA-326 suppresses the proliferation, migration and invasion of cervical cancer cells by targeting ELK1. Oncol Lett. 2017;13(5):2949\u201356.","journal-title":"Oncol Lett"},{"issue":"24","key":"2744_CR100","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.21037\/atm-20-6830","volume":"8","author":"J Zhang","year":"2020","unstructured":"Zhang J, et al. miR-326 inhibits the cell proliferation and cancer stem cell-like property of cervical cancer in vitro and oncogenesis in vivo via targeting TCF4. Annals Translat Med. 2020;8(24):1637.","journal-title":"Annals Translat Med"},{"issue":"12","key":"2744_CR101","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1080\/15384047.2018.1491497","volume":"19","author":"Y-F Wang","year":"2018","unstructured":"Wang Y-F, et al. Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer. Cancer Biol Ther. 2018;19(12):1162\u201373.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"2744_CR102","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3892\/etm.2015.2911","volume":"11","author":"L-F Che","year":"2016","unstructured":"Che L-F, Shao SF, Wang LX. Downregulation of CCR5 inhibits the proliferation and invasion of cervical cancer cells and is regulated by microRNA-107. Exp Ther Med. 2016;11(2):503\u20139.","journal-title":"Exp Ther Med"},{"issue":"3","key":"2744_CR103","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41419-018-0431-2","volume":"9","author":"F Fang","year":"2018","unstructured":"Fang F, et al. miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-\u03b2RI signaling pathway. Cell Death Dis. 2018;9(3):395.","journal-title":"Cell Death Dis"},{"issue":"6","key":"2744_CR104","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.3892\/mmr.2020.11552","volume":"22","author":"Y Guo","year":"2020","unstructured":"Guo Y, Luo S. miR-140-5p inhibits cervical cancer cell phenotypes via downregulating FEN1 to halt the cell cycle. Mol Med Rep. 2020;22(6):4919\u201330.","journal-title":"Mol Med Rep"},{"issue":"3","key":"2744_CR105","first-page":"3075","volume":"15","author":"L Cheng","year":"2018","unstructured":"Cheng L, et al. miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression. Oncol Lett. 2018;15(3):3075\u201380.","journal-title":"Oncol Lett"},{"issue":"1","key":"2744_CR106","doi-asserted-by":"publisher","first-page":"155932582110012","DOI":"10.1177\/15593258211001255","volume":"19","author":"C-X Wen","year":"2021","unstructured":"Wen C-X, et al. MiRNA-873-5p acts as a potential novel biomarker and promotes cervical cancer progression by regulating ZEB1 via notch signaling pathway. Dose-Response. 2021;19(1):15593258211001256.","journal-title":"Dose-Response"},{"issue":"1","key":"2744_CR107","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10528-021-10098-z","volume":"60","author":"Y Yang","year":"2022","unstructured":"Yang Y, et al. miR-122 inhibits the cervical cancer development by targeting the oncogene RAD21. Biochem Genet. 2022;60(1):303\u201314.","journal-title":"Biochem Genet"},{"issue":"5","key":"2744_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.11961","volume":"23","author":"H-M Ding","year":"2021","unstructured":"Ding H-M, et al. miR-302c-3p and miR-520a-3p suppress the proliferation of cervical carcinoma cells by targeting CXCL8. Mol Med Rep. 2021;23(5):1\u201310.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2744_CR109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-020-02109-x","volume":"19","author":"X Lu","year":"2021","unstructured":"Lu X, et al. MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1. World J Surgic Oncol. 2021;19(1):1\u201310.","journal-title":"World J Surgic Oncol"},{"key":"2744_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117558","volume":"254","author":"L Zhang","year":"2020","unstructured":"Zhang L, et al. MiR-520d-5p functions as a tumor-suppressor gene in cervical cancer through targeting PTK2. Life Sci. 2020;254: 117558.","journal-title":"Life Sci"},{"issue":"28","key":"2744_CR111","doi-asserted-by":"publisher","first-page":"25266","DOI":"10.18632\/oncotarget.4457","volume":"6","author":"Z Fan","year":"2015","unstructured":"Fan Z, et al. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3. Oncotarget. 2015;6(28):25266.","journal-title":"Oncotarget"},{"issue":"2","key":"2744_CR112","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3892\/or.2015.4013","volume":"34","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, et al. MicroRNA-491\u20135p suppresses cervical cancer cell growth by targeting hTERT. Oncol Reports. 2015;34(2):979\u201386.","journal-title":"Oncol Reports"},{"issue":"1","key":"2744_CR113","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/cam4.3601","volume":"10","author":"S Yang","year":"2021","unstructured":"Yang S, et al. MiR-362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGF\u03b2\/Smad pathway. Cancer Med. 2021;10(1):305\u201316.","journal-title":"Cancer Med"},{"key":"2744_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120268","volume":"291","author":"P Sharma","year":"2022","unstructured":"Sharma P, et al. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells. Life Sci. 2022;291: 120268.","journal-title":"Life Sci"},{"key":"2744_CR115","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.omtn.2020.05.015","volume":"21","author":"J Yu","year":"2020","unstructured":"Yu J, et al. Functional significance and therapeutic potential of miRNA-20b-5p in esophageal squamous cell carcinoma. Mol Therapy Nucleic Acids. 2020;21:315\u201331.","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"11","key":"2744_CR116","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s12094-021-02687-6","volume":"23","author":"J Tang","year":"2021","unstructured":"Tang J, et al. MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer. Clin Transl Oncol. 2021;23(11):2323\u201334.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"2744_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2019.115283","volume":"28","author":"J Ma","year":"2020","unstructured":"Ma J, Zhang F, Sun P. miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis. Bioorg Med Chem. 2020;28(3): 115283.","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"2744_CR118","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/kjm2.12398","volume":"37","author":"RF Dong","year":"2021","unstructured":"Dong RF, et al. Tumor suppressor miR-192-5p targets TRPM7 and inhibits proliferation and invasion in cervical cancer. Kaohsiung J Med Sci. 2021;37(8):699\u2013708.","journal-title":"Kaohsiung J Med Sci"},{"issue":"3","key":"2744_CR119","first-page":"2059","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Feng J, Zhang A. miR-584 inhibits cell proliferation, migration and invasion in vitro and enhances the sensitivity to cisplatin in human cervical cancer by negatively targeting GLI1. Exp Ther Med. 2020;19(3):2059\u201366.","journal-title":"Exp Ther Med"},{"key":"2744_CR120","doi-asserted-by":"publisher","first-page":"153303382094224","DOI":"10.1177\/1533033820942245","volume":"19","author":"X Yang","year":"2020","unstructured":"Yang X, et al. MicroRNA-199a inhibits cell proliferation, migration, and invasion and activates AKT\/mTOR signaling pathway by targeting B7\u2013H3 in cervical cancer. Technol Cancer Res Treat. 2020;19:1533033820942245.","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"2744_CR121","doi-asserted-by":"publisher","first-page":"125","DOI":"10.21037\/atm-20-7272","volume":"9","author":"T Zou","year":"2021","unstructured":"Zou T, Gao Y, Qie M. MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC. Annals Translat Med. 2021;9(2):125.","journal-title":"Annals Translat Med"},{"issue":"2","key":"2744_CR122","first-page":"1","volume":"23","author":"H Wei","year":"2021","unstructured":"Wei H, et al. miR-34c-5p targets Notch1 and suppresses the metastasis and invasion of cervical cancer. Mol Med Rep. 2021;23(2):1\u20131.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2744_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01209-8","volume":"20","author":"Q Cao","year":"2020","unstructured":"Cao Q, et al. miR-125a-5p post-transcriptionally suppresses GALNT7 to inhibit proliferation and invasion in cervical cancer cells via the EGFR\/PI3K\/AKT pathway. Cancer Cell Int. 2020;20(1):1\u201313.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2744_CR124","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1186\/s12885-022-09970-x","volume":"22","author":"M Li","year":"2022","unstructured":"Li M, et al. MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell. BMC Cancer. 2022;22(1):876.","journal-title":"BMC Cancer"},{"issue":"4","key":"2744_CR125","first-page":"463","volume":"25","author":"C Wang","year":"2017","unstructured":"Wang C, et al. miR-126-5p restoration promotes cell apoptosis in cervical cancer by targeting Bcl2l2. Oncol Res Featur Preclin Clin Cancer Therapeut. 2017;25(4):463\u201370.","journal-title":"Oncol Res Featur Preclin Clin Cancer Therapeut"},{"issue":"5","key":"2744_CR126","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/kjm2.12181","volume":"36","author":"QL Hu","year":"2020","unstructured":"Hu QL, et al. miR-636 represses cell survival by targeting CDK6\/Bcl-2 in cervical cancer. Kaohsiung J Med Sci. 2020;36(5):328\u201335.","journal-title":"Kaohsiung J Med Sci"},{"key":"2744_CR127","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.biopha.2016.07.050","volume":"83","author":"P Huang","year":"2016","unstructured":"Huang P, Xi J, Liu S. MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1. Biomed Pharmacother. 2016;83:850\u20136.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"2744_CR128","first-page":"10148","volume":"8","author":"C Lin","year":"2015","unstructured":"Lin C, et al. MicroRNA-101 regulates the viability and invasion of cervical cancer cells. Int J Clin Exp Pathol. 2015;8(9):10148.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"2744_CR129","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/jcb.27438","volume":"120","author":"A Shang","year":"2019","unstructured":"Shang A, et al. miR-381-3p restrains cervical cancer progression by downregulating FGF7. J Cell Biochem. 2019;120(1):778\u201389.","journal-title":"J Cell Biochem"},{"issue":"9","key":"2744_CR130","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.1002\/jcp.26574","volume":"233","author":"GC Li","year":"2018","unstructured":"Li GC, et al. MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38\/ERK signaling pathway by binding to JAM-2. J Cell Physiol. 2018;233(9):7379\u201390.","journal-title":"J Cell Physiol"},{"issue":"1","key":"2744_CR131","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1080\/21691401.2019.1628038","volume":"47","author":"N Li","year":"2019","unstructured":"Li N, et al. Molecular mechanism of miR-204 regulates proliferation, apoptosis and autophagy of cervical cancer cells by targeting ATF2. Artific Cells Nanomed Biotechnol. 2019;47(1):2529\u201335.","journal-title":"Artific Cells Nanomed Biotechnol"},{"key":"2744_CR132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-017-1299-9","volume":"16","author":"L Zhu","year":"2018","unstructured":"Zhu L, et al. MiR-218 produces anti-tumor effects on cervical cancer cells in vitro. World J Surgic Oncol. 2018;16:1\u201310.","journal-title":"World J Surgic Oncol"},{"key":"2744_CR133","doi-asserted-by":"publisher","first-page":"8931","DOI":"10.1007\/s13277-015-4771-6","volume":"37","author":"T Zhang","year":"2016","unstructured":"Zhang T, et al. Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer. Tumor Biol. 2016;37:8931\u201340.","journal-title":"Tumor Biol"},{"issue":"7","key":"2744_CR134","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3727\/096504018X15152056890500","volume":"26","author":"L Jiang","year":"2018","unstructured":"Jiang L, et al. MicroRNA-519d-3p inhibits proliferation and promotes apoptosis by targeting HIF-2\u03b1 in cervical cancer under hypoxic conditions. Oncol Res. 2018;26(7):1055.","journal-title":"Oncol Res"},{"issue":"4","key":"2744_CR135","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1248\/cpb.c20-00600","volume":"69","author":"J Xu","year":"2021","unstructured":"Xu J, et al. MiR-509-3p induces apoptosis and affects the chemosensitivity of cervical cancer cells by targeting the RAC1\/PAK1\/LIMK1\/cofilin pathway. Chem Pharm Bull. 2021;69(4):325\u201332.","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"2744_CR136","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jcp.28957","volume":"235","author":"H Sun","year":"2020","unstructured":"Sun H, et al. miR-4429 sensitized cervical cancer cells to irradiation by targeting RAD51. J Cell Physiol. 2020;235(1):185\u201393.","journal-title":"J Cell Physiol"},{"issue":"6","key":"2744_CR137","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.febslet.2015.01.037","volume":"589","author":"C Ye","year":"2015","unstructured":"Ye C, et al. MicroRNA-145 contributes to enhancing radiosensitivity of cervical cancer cells. FEBS Lett. 2015;589(6):702\u20139.","journal-title":"FEBS Lett"},{"issue":"1","key":"2744_CR138","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bbrc.2018.11.110","volume":"508","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, et al. Role and mechanism of miR-4778-3p and its targets NR2C2 and Med19 in cervical cancer radioresistance. Biochem Biophys Res Commun. 2019;508(1):210\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"02","key":"2744_CR139","doi-asserted-by":"publisher","first-page":"079","DOI":"10.4103\/2278-330X.181646","volume":"5","author":"DB Nikumbh","year":"2016","unstructured":"Nikumbh DB, Nikumbh RD, Kanthikar SN. Limitations of cytological cervical cancer screening (Papanicolaou test) regarding technical and cultural aspect in rural India. South Asian J Cancer. 2016;5(02):079\u2013079.","journal-title":"South Asian J Cancer"},{"issue":"18","key":"2744_CR140","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.2174\/1389557522666220303141558","volume":"22","author":"SL Teoh","year":"2022","unstructured":"Teoh SL, Das S. MicroRNAs in various body fluids and their importance in forensic medicine. Mini Rev Med Chem. 2022;22(18):2332\u201343.","journal-title":"Mini Rev Med Chem"},{"issue":"2","key":"2744_CR141","doi-asserted-by":"publisher","first-page":"54","DOI":"10.31083\/j.ceog4902054","volume":"49","author":"P He","year":"2022","unstructured":"He P, et al. miR-34a-5p enhances the sensitivity of cervical cancer cells to oxaliplatin chemotherapy via targeting MDM4. Clin Exp Obstet Gynecol. 2022;49(2):54.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"2","key":"2744_CR142","first-page":"312","volume":"6","author":"R Zhang","year":"2016","unstructured":"Zhang R, et al. HPV E6\/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer. Am J Cancer Res. 2016;6(2):312.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2744_CR143","first-page":"1","volume":"21","author":"A Lv","year":"2021","unstructured":"Lv A, et al. Circulating exosomal miR-125a-5p as a novel biomarker for cervical cancer. Oncol Lett. 2021;21(1):1\u20131.","journal-title":"Oncol Lett"},{"issue":"1","key":"2744_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-0999-x","volume":"18","author":"M Zheng","year":"2019","unstructured":"Zheng M, et al. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors. Mol Cancer. 2019;18(1):1\u20138.","journal-title":"Mol Cancer"},{"issue":"1","key":"2744_CR145","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12859-021-04261-x","volume":"22","author":"D Ding","year":"2021","unstructured":"Ding D, et al. Machine learning-based prediction of survival prognosis in cervical cancer. BMC Bioinformat. 2021;22(1):331.","journal-title":"BMC Bioinformat"},{"issue":"1","key":"2744_CR146","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3892\/mco.2016.875","volume":"5","author":"Y Nagamitsu","year":"2016","unstructured":"Nagamitsu Y, et al. Profiling analysis of circulating microRNA expression in cervical cancer. Mol Clin Oncol. 2016;5(1):189\u201394.","journal-title":"Mol Clin Oncol"},{"issue":"8","key":"2744_CR147","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/gtmb.2013.0085","volume":"17","author":"S Zhao","year":"2013","unstructured":"Zhao S, et al. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer. Genet Test Mol Biomarkers. 2013;17(8):631\u20136.","journal-title":"Genet Test Mol Biomarkers"},{"key":"2744_CR148","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.biopha.2017.09.143","volume":"97","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, et al. MicroRNA-150 promotes cell proliferation, migration, and invasion of cervical cancer through targeting PDCD4. Biomed Pharmacother. 2018;97:511\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2744_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-014-0081-0","volume":"14","author":"Q Ma","year":"2014","unstructured":"Ma Q, et al. Serum microRNA-205 as a novel biomarker for cervical cancer patients. Cancer Cell Int. 2014;14(1):1\u20137.","journal-title":"Cancer Cell Int"},{"issue":"23","key":"2744_CR150","first-page":"4846","volume":"20","author":"F Xin","year":"2016","unstructured":"Xin F, Liu P, Ma C. A circulating serum miRNA panel as early detection biomarkers of cervical intraepithelial neoplasia. Eur Rev Med Pharmacol Sci. 2016;20(23):4846\u201351.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2744_CR151","doi-asserted-by":"crossref","unstructured":"Luo Q, Wang H, Li J. Serum miR-3142 could be used as a potential biomarker to screen cervical cancer patients from healthy controls. Clin Laborat. 2019. 65(4).","DOI":"10.7754\/Clin.Lab.2018.180925"},{"key":"2744_CR152","doi-asserted-by":"publisher","first-page":"153303382199528","DOI":"10.1177\/1533033821995281","volume":"20","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Diagnostic value of vaginal microecology, serum miR-18a, and PD-L1 for identifying HPV-positive cervical cancer. Technol Cancer Res Treat. 2021;20:1533033821995281.","journal-title":"Technol Cancer Res Treat"},{"issue":"5","key":"2744_CR153","first-page":"1518","volume":"12","author":"H Lu","year":"2019","unstructured":"Lu H, Gu X. MicroRNA-221 inhibits human papillomavirus 16 E1\u2013E2 mediated DNA replication through activating SOCS1\/Type I IFN signaling pathway. Int J Clin Exp Pathol. 2019;12(5):1518.","journal-title":"Int J Clin Exp Pathol"},{"key":"2744_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-019-1220-y","volume":"16","author":"M Farzanehpour","year":"2019","unstructured":"Farzanehpour M, et al. Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer. Virology J. 2019;16:1\u20139.","journal-title":"Virology J"},{"key":"2744_CR155","doi-asserted-by":"publisher","first-page":"153303382098008","DOI":"10.1177\/1533033820980081","volume":"19","author":"Y Cai","year":"2020","unstructured":"Cai Y, et al. Inhibition of microrna-766-5p attenuates the development of cervical cancer through regulating SCAI. Technol Cancer Res Treat. 2020;19:1533033820980081.","journal-title":"Technol Cancer Res Treat"},{"issue":"6","key":"2744_CR156","first-page":"5693","volume":"17","author":"D Yang","year":"2019","unstructured":"Yang D, Zhang Q. miR-152 may function as an early diagnostic and prognostic biomarker in patients with cervical intraepithelial neoplasia and patients with cervical cancer. Oncol Lett. 2019;17(6):5693\u20138.","journal-title":"Oncol Lett"},{"issue":"4","key":"2744_CR157","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3892\/mco.2015.560","volume":"3","author":"W Jia","year":"2015","unstructured":"Jia W, et al. Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring. Mol Clin Oncol. 2015;3(4):851\u20138.","journal-title":"Mol Clin Oncol"},{"issue":"12","key":"2744_CR158","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1016\/j.bbadis.2018.09.028","volume":"1864","author":"J Wang","year":"2018","unstructured":"Wang J, et al. MiR-1266 promotes cell proliferation, migration and invasion in cervical cancer by targeting DAB2IP. Biochimica et Biophysica Acta Mol Basis Dis. 2018;1864(12):3623\u201330.","journal-title":"Biochimica et Biophysica Acta Mol Basis Dis"},{"issue":"1","key":"2744_CR159","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0004563216649377","volume":"54","author":"L Sun","year":"2017","unstructured":"Sun L, et al. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer. Ann Clin Biochem. 2017;54(1):127\u201333.","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"2744_CR160","doi-asserted-by":"publisher","first-page":"17942","DOI":"10.1038\/srep17942","volume":"5","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, et al. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer. Sci Rep. 2015;5(1):17942.","journal-title":"Sci Rep"},{"issue":"2","key":"2744_CR161","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/apm.13093","volume":"129","author":"R Ocadiz-Delgado","year":"2021","unstructured":"Ocadiz-Delgado R, et al. Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis. APMIS. 2021;129(2):70\u20139.","journal-title":"APMIS"},{"key":"2744_CR162","doi-asserted-by":"publisher","first-page":"153303382097066","DOI":"10.1177\/1533033820970667","volume":"19","author":"H Qiu","year":"2020","unstructured":"Qiu H, et al. A novel circulating miRNA-based signature for the diagnosis and prognosis prediction of early-stage cervical cancer. Technol Cancer Res Treat. 2020;19:1533033820970667.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"2744_CR163","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ygyno.2019.08.012","volume":"155","author":"V Shukla","year":"2019","unstructured":"Shukla V, et al. Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer. Gynecol Oncol. 2019;155(1):135\u201343.","journal-title":"Gynecol Oncol"},{"key":"2744_CR164","doi-asserted-by":"publisher","first-page":"153303382091498","DOI":"10.1177\/1533033820914983","volume":"19","author":"F Ruan","year":"2020","unstructured":"Ruan F, Wang Y-F, Chai Y. Diagnostic values of miR-21, miR-124, and M-CSF in patients with early cervical cancer. Technol Cancer Res Treat. 2020;19:1533033820914983.","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"2744_CR165","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3233\/CBM-201021","volume":"32","author":"Z Yamanaka","year":"2021","unstructured":"Yamanaka Z, et al. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer. Cancer Biomark. 2021;32(4):551\u20138.","journal-title":"Cancer Biomark"},{"key":"2744_CR166","doi-asserted-by":"publisher","first-page":"8387458","DOI":"10.1155\/2022\/8387458","volume":"2022","author":"D Zhu","year":"2022","unstructured":"Zhu D, et al. LncRNA ABHD11-AS1 participates in the progression of cervical carcinoma by targeting miR-1254 and is the key to the diagnosis and treatment of cervical carcinoma in the future. J Healthcare Eng. 2022;2022:8387458.","journal-title":"J Healthcare Eng"},{"issue":"3","key":"2744_CR167","first-page":"213","volume":"34","author":"L Zhang","year":"2021","unstructured":"Zhang L, Wu ZA. MicroRNA-378a-3p downregulation as a novel biomarker with poor clinical outcomes in cervical cancer. Biomed Environ Sci. 2021;34(3):213\u201321.","journal-title":"Biomed Environ Sci"},{"issue":"5","key":"2744_CR168","first-page":"2809","volume":"37","author":"D Li","year":"2021","unstructured":"Li D, Ge X, Liu P. Changes of Mir-144-3p and Mir-337-3p in serum of cervical carcinoma patients and analysis of diagnosis and prognosis. Acta Medica Mediterranea. 2021;37(5):2809\u201315.","journal-title":"Acta Medica Mediterranea"},{"key":"2744_CR169","doi-asserted-by":"publisher","first-page":"12723","DOI":"10.2147\/CMAR.S267634","volume":"12","author":"J Sun","year":"2020","unstructured":"Sun J, et al. MiR-139\u20135p-ZEB1 is a molecular regulator of growth, invasion, and epithelial-to-mesenchymal transition of cervical cancer. Cancer Manage Res. 2020;12:12723\u201333.","journal-title":"Cancer Manage Res"},{"key":"2744_CR170","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.2147\/CMAR.S312469","volume":"13","author":"S Cao","year":"2021","unstructured":"Cao S, Li H, Li L. LncRNA SNHG17 contributes to the progression of cervical cancer by targeting microRNA-375\u20133p. Cancer Manage Res. 2021;13:4969\u201378.","journal-title":"Cancer Manage Res"},{"issue":"4","key":"2744_CR171","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1089\/gtmb.2019.0147","volume":"24","author":"S Zheng","year":"2020","unstructured":"Zheng S, et al. Serum miR-638 combined with squamous cell carcinoma-related antigen as potential screening biomarkers for cervical squamous cell carcinoma. Genet Test Mol Biomarkers. 2020;24(4):188\u201394.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"11","key":"2744_CR172","first-page":"8326","volume":"13","author":"Z Li","year":"2020","unstructured":"Li Z, Lin Y. LncRNA TUG1 accelerates cervical cancer progression through miR-29b. Int J Clin Exp Med. 2020;13(11):8326\u201339.","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"2744_CR173","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.3892\/etm.2017.4887","volume":"14","author":"X Meng","year":"2017","unstructured":"Meng X, et al. Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer. Exp Ther Med. 2017;14(4):2789\u201394.","journal-title":"Exp Ther Med"},{"issue":"4","key":"2744_CR174","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3233\/CBM-190256","volume":"26","author":"G Ma","year":"2019","unstructured":"Ma G, et al. Circulating plasma microRNA signature for the diagnosis of cervical cancer. Cancer Biomark. 2019;26(4):491\u2013500.","journal-title":"Cancer Biomark"},{"key":"2744_CR175","unstructured":"AL-Temimi SM, Alzubaidy SAAK, Adel Mosa AL-Rekabi S. Down-regulation of Microrna-432 in cervical mucus as a Pioneer marker in early detection of cervical cancer. Annals Roman Soc Cell Biol. 2021: p. 9865\u20139870."},{"issue":"1","key":"2744_CR176","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.1038\/s41598-018-25310-1","volume":"8","author":"S Kawai","year":"2018","unstructured":"Kawai S, et al. Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia. Sci Rep. 2018;8(1):7070.","journal-title":"Sci Rep"},{"issue":"12","key":"2744_CR177","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/carcin\/bgaa046","volume":"41","author":"J Wittenborn","year":"2020","unstructured":"Wittenborn J, et al. The use of micro RNA in the early detection of cervical intraepithelial neoplasia. Carcinogenesis. 2020;41(12):1781\u20139.","journal-title":"Carcinogenesis"},{"issue":"4","key":"2744_CR178","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.31557\/APJCP.2021.22.4.1271","volume":"22","author":"T Azimi","year":"2021","unstructured":"Azimi T, et al. Pap Smear miR-92a-5p and miR-155-5p as potential diagnostic biomarkers of squamous intraepithelial cervical cancer. Asian Pacific J Cancer Prevent. 2021;22(4):1271.","journal-title":"Asian Pacific J Cancer Prevent"},{"issue":"1","key":"2744_CR179","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","volume":"5","author":"J Dai","year":"2020","unstructured":"Dai J, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5(1):145.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"2744_CR180","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41419-020-03140-2","volume":"11","author":"Q Gou","year":"2020","unstructured":"Gou Q, et al. PD-L1 degradation pathway and immunotherapy for cancer. Cell Death Dis. 2020;11(11):955.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2744_CR181","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12929-024-00998-8","volume":"31","author":"YR Li","year":"2024","unstructured":"Li YR, Halladay T, Yang L. Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies. J Biomed Sci. 2024;31(1):5.","journal-title":"J Biomed Sci"},{"key":"2744_CR182","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2017.00561","volume":"8","author":"HO Alsaab","year":"2017","unstructured":"Alsaab HO, et al. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol. 2017;8:561.","journal-title":"Front Pharmacol"},{"issue":"12","key":"2744_CR183","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/carcin\/bgad072","volume":"44","author":"Z Jiao","year":"2023","unstructured":"Jiao Z, Zhang J. Interplay between inflammasomes and PD-1\/PD-L1 and their implications in cancer immunotherapy. Carcinogenesis. 2023;44(12):795\u2013808.","journal-title":"Carcinogenesis"},{"key":"2744_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.568931","volume":"11","author":"K Hudson","year":"2020","unstructured":"Hudson K, et al. The extrinsic and intrinsic roles of PD-L1 and its receptor PD-1: implications for immunotherapy treatment. Front Immunol. 2020;11: 568931.","journal-title":"Front Immunol"},{"issue":"1","key":"2744_CR185","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/bjc.2017.390","volume":"118","author":"S Markovina","year":"2018","unstructured":"Markovina S, et al. Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer. Br J Cancer. 2018;118(1):72\u20138.","journal-title":"Br J Cancer"},{"key":"2744_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-06934-x","volume":"20","author":"P Chen","year":"2020","unstructured":"Chen P, et al. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma. BMC Cancer. 2020;20:1\u201310.","journal-title":"BMC Cancer"},{"issue":"9","key":"2744_CR187","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.3390\/ijms23095167","volume":"23","author":"R Di Fiore","year":"2022","unstructured":"Di Fiore R, et al. Cancer stem cells and their possible implications in cervical cancer: a short review. Int J Mol Sci. 2022;23(9):5167.","journal-title":"Int J Mol Sci"},{"key":"2744_CR188","doi-asserted-by":"publisher","first-page":"1397945","DOI":"10.3389\/fcell.2024.1397945","volume":"12","author":"P Chauhan","year":"2024","unstructured":"Chauhan P, et al. Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses. Front Cell Develop Bio. 2024;12:1397945.","journal-title":"Front Cell Develop Bio"},{"key":"2744_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.847974","volume":"12","author":"G Ravegnini","year":"2022","unstructured":"Ravegnini G, et al. Emerging role of MicroRNAs in the therapeutic response in cervical cancer: a systematic review. Front Oncol. 2022;12: 847974.","journal-title":"Front Oncol"},{"issue":"4","key":"2744_CR190","first-page":"1300","volume":"43","author":"R Ichikawa","year":"2020","unstructured":"Ichikawa R, et al. MicroRNA-126-3p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K\/PDK1\/AKT pathway. Oncol Rep. 2020;43(4):1300\u20138.","journal-title":"Oncol Rep"},{"key":"2744_CR191","first-page":"1","volume":"2020","author":"Y Wu","year":"2020","unstructured":"Wu Y, et al. Changes of miRNA expression profiles from cervical-vaginal fluid-derived exosomes in response to HPV16 infection. Biomed Res Int. 2020;2020:1\u20138.","journal-title":"Biomed Res Int"},{"key":"2744_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4590-4","volume":"18","author":"B Pardini","year":"2018","unstructured":"Pardini B, et al. MicroRNAs as markers of progression in cervical cancer: a systematic review. BMC Cancer. 2018;18:1\u201317.","journal-title":"BMC Cancer"},{"issue":"5","key":"2744_CR193","first-page":"3650","volume":"18","author":"F Meng","year":"2019","unstructured":"Meng F, et al. MicroRNA-877 is downregulated in cervical cancer and directly targets MACC1 to inhibit cell proliferation and invasion. Exp Ther Med. 2019;18(5):3650\u20138.","journal-title":"Exp Ther Med"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02744-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T14:01:50Z","timestamp":1748181710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":193,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2744"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02744-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During manuscript preparation, the authors utilized AI-assisted tools (Microsoft Bing) for editing and paraphrasing. The authors reviewed and edited all content and take full responsibility for the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The systematic review and meta-analysis utilized published data from indexed journals. The analysis was conducted under ethical approval IR.TBZMED.REC.1400.438.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"922"}}